Researcher
Veerle SOMERS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, General diagnostics, Adaptive immunology, Musculo-skeletal systems, Developmental neuroscience
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From11 Dec 2003 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jan 2003 → Today - Immunology - Biochemistry (Research group)
Member
From11 Dec 2003 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From16 Jan 2003 → 30 Sep 2009
Projects
11 - 20 of 48
- Further large-scale validation of axSpA biomarkers using a clinically applicable peptide-ELISAFrom1 Apr 2020 → 30 Sep 2021Funding: IOF - technology concept exploration
- Further deepening of the market potential of new biomarkers for the diagnosis of axial spondyloarthritisFrom1 Jan 2020 → 31 Dec 2020Funding: IOF - technology concept exploration
- Validation of age-associated B cells as therapeutic targets in MSFrom1 Jan 2020 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
- Spinal cord injury induced autoantibodies as biomarkers that predict disease courseFrom1 Nov 2019 → 31 Oct 2020Funding: BOF - doctoral mandates
- Taxonomy, Treatment, Targets and Remission: Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic ConditionsFrom1 Sep 2019 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- Maternal Autoantibodies as predictive biomarkers for Autism Spectrum DisorderFrom9 Jan 2019 → 31 Dec 2020Funding: Nonprofit institution or equivalents
- Autologous hematopoietic stem cell transplantation (AHSCT) in MS: a role for B cells?From1 Jan 2019 → 30 Jun 2022Funding: Foundations, funds and other with scientific goal
- Age-associated B cells as therapeutic targets in MSFrom1 Jan 2019 → 30 Jun 2022Funding: Foundations, funds and other with scientific goal
- Maternal antibodies as predictive biomarkers for Autism Spectrum DisorderFrom1 Jan 2019 → 31 Dec 2020Funding: Foreign foundations, funds with scientific view
- T-bet induced age-associated B cells contribute to multiple sclerosis pathology and progressionFrom1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
Publications
1 - 10 of 127
- Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab(2024)
Authors: Lien BECKERS, Paulien BAETEN, Veronica POPESCU, Dries SWINNEN, Alessio CARDILLI, Ibrahim HAMAD, Bart VAN WIJMEERSCH, S.J. Tavernier, Markus KLEINEWIETFELD, Bieke BROUX, et al.
Pages: 109894 - Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis(2023)
Authors: Rut MAZON CABRERA, Jori LIESENBORGS, Bert BRONE, Patrick VANDORMAEL, Veerle SOMERS
- ANTIBODIES OF THE IMMUNOGLOBULIN G AND A ISOTYPE TO NOVEL PEPTIDES IN EARLY AXIAL SPONDYLOARTHRITIS PATIENTS(2023)
Authors: Pieter RUYTINX, Patrick VANDORMAEL, Dana QUADEN, Elien LUYTEN, P. Geusens, Johan VANHOOF, Anouk AGTEN, Frank VANDENABEELE, K. De Vlam, Veerle SOMERS
Pages: 1225 - IgD−CD27− double negative (DN) B cells: Origins and functions in health and disease(2023)
Authors: Lien BECKERS, Veerle SOMERS, Judith FRAUSSEN
Pages: 67 - 76 - Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort(2023)
Authors: Pieter RUYTINX, Patrick VANDORMAEL, Judith FRAUSSEN, Zoe PIETERS, Stef Thonissen, Niels HELLINGS, Piet STINISSEN, Ina CALLEBAUT, Joris PENDERS, Karolien VANHOVE, et al.
- Antibodies of the immunoglobulin a isotype to novel antigens in early axial spondyloarthritis(2023)
Authors: Pieter RUYTINX, Patrick VANDORMAEL, Dana QUADEN, Elien LUYTEN, Piet GEUSENS, Johan VANHOOF, Anouk AGTEN, Frank VANDENABEELE, Kurt de Vlam, Veerle SOMERS
- ANTIBODIES TO TWO NOVEL PEPTIDES IN NEW ONSET AXIAL SPONDYLOARTHRITIS(2022)
Authors: Pieter RUYTINX, P. Vandormael, Elien LUYTEN, A. S. De Craemer, F. Van den Bosch, D. Elewaut, Veerle SOMERS
Pages: 799 - Editorial: New Insights Into B Cell Subsets in Health and Disease(2022)
Authors: Veerle SOMERS, Deborah K. Dunn-Walters, Mirjam van der Burg, Judith FRAUSSEN
- Altered Circulating Immune Cell Distribution in Traumatic Spinal Cord Injury Patients in Relation to Clinical Parameters(2022)
Authors: Judith FRAUSSEN, Lien BECKERS, CCM van Laake-Geelen, B Depreitere, J Deckers, EMJ Cornips, D Peuskens, Veerle SOMERS
- Studying the clinical, radiological, histological, microbiological, and immunological evolution during the different COVID-19 disease stages using minimal invasive autopsy(2022)
Authors: Valentino D'ONOFRIO, Lotte Keulen, Annelore Vandendriessche, Jasperina Dubois, Reinoud Cartuyvels, Marie-Elena Vanden Abeele, Judith FRAUSSEN, Patrick VANDORMAEL, Veerle SOMERS, Ruth ACHTEN, et al.
Patents
1 - 9 of 9
- Method and means for diagnosis of spondyloarthritis (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)